BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/1/2021 3:51:08 AM | Browse: 588 | Download: 1117
 |
Received |
|
2020-09-23 14:05 |
|
Peer-Review Started |
|
2020-09-23 14:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-14 01:37 |
|
Revised |
|
2020-12-26 13:23 |
|
Second Decision |
|
2021-01-06 10:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-01-06 16:45 |
|
Articles in Press |
|
2021-01-06 16:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-01-20 23:57 |
|
Typeset the Manuscript |
|
2021-02-24 02:26 |
|
Publish the Manuscript Online |
|
2021-03-01 03:51 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Man Li, Xiao-Yu Pu, Li-Hua Dong and Peng-Yu Chang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li-Hua Dong, PhD, Chief Physician, Department of Radiation Oncology, The First Hospital of Jilin University, No. 71, Xinmin Street, Changchun 130021, Jilin Province, China. drlhdong@163.com |
| Key Words |
Radiotherapy; Chemotherapy; Case report; Thymic adenocarcinoma; Anti-angiogenic therapy; Thymic-enteric adenocarcinoma type |
| Core Tip |
This report introduces the diagnosis and treatment of a metastatic thymic-enteric adenocarcinoma type with positive expression of CDX2 and CK20. For the first time, radiotherapy and chemotherapy combined with anti-angiogenesis therapy were used. The tumor was partially remitted, and there was no sign of recurrence. XELOX (capecitabine plus oxaliplatin) combined with radiotherapy is an alternative treatment of inoperable metastatic thymic-enteric adenocarcinoma. |
| Publish Date |
2021-03-01 03:51 |
| Citation |
Li M, Pu X, Dong L, Chang P. Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i7/1676.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i7.1676 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
